-
Baird Upgrades Medpace (MEDP) to Outperform
-
Medpace (MEDP) PT Lowered to $485 at Leerink Partners
-
Medpace (MEDP) PT Lowered to $500 at Barclays
-
After-hours movers: ON Semiconductor, Credo, Upwork, Regenxbio, and more
-
Medpace Holdings (MEDP) Tops Q4 EPS by 49c, Beats on Revenue; Offers FY26 Revenue Guidance
-
Medpace (MEDP) PT Raised to $555 at Truist, 'Riding on the Biotech Recovery'
-
Medpace (MEDP) PT Raised to $575 at Leerink Partners
-
Medpace Holdings (MEDP) Tops Q3 EPS by 33c, provides guidance
-
Barclays Downgrades Medpace (MEDP) to Underweight
-
Rothschild Redburn Downgrades Medpace (MEDP) to Neutral
-
UBS Downgrades Medpace (MEDP) to Sell
-
TD Cowen Downgrades Medpace (MEDP) to Sell
-
Medpace Holdings (MEDP) call put ratio 1 call to 4.3 puts with a focus on September 390, 400 and 420 puts as share price up 57%
-
UBS Reiterates Neutral Rating on Medpace (MEDP)
-
Medpace Holdings (MEDP) Tops Q2 EPS by 12c, provides guidance
-
Barclays Starts Medpace (MEDP) at Equalweight
-
Truist Reiterates Hold Rating on Medpace (MEDP) Amid 'Choppy Macro'
-
William Blair Downgrades Medpace (MEDP) to Market Perform 'Due to Challenging Demand Environment'
-
TD Cowen on Medpace (MEDP): 'Weak B2B Signals Macro Enviorment'
-
Medpace Holdings (MEDP) Tops Q1 EPS by 62c; offers guidance
-
TD Cowen Downgrades Medpace (MEDP) to Hold
-
Medpace Holdings (MEDP) Tops Q4 EPS by 73c, provides guidance
-
Medpace (MEDP) PT Lowered to $370 at TD Cowen
-
Medpace (MEDP) PT Raised to $354 at Baird
-
Baird Downgrades Medpace (MEDP) to Neutral
-
TD Cowen Reiterates Buy Rating on Medpace (MEDP)
-
After-hours movers: NANO Nuclear Energy, DMC Global, Zions Bancorp, and more
-
Medpace Holdings (MEDP) Tops Q3 EPS by 23c ; Offers Guidance
-
Redburn-Atlantic Starts Medpace (MEDP) at Buy
-
UBS Downgrades Medpace (MEDP) to Neutral
-
Investors should cut exposure to CROs as biotech market slows: Jefferies
-
Jefferies Downgrades Medpace (MEDP) to Hold
-
Berry (BERY) and Glatfelter (GLT) Announce Magnera Board of Director Appointments in Connection With Proposed Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business Wi
-
Truist Securities Starts Medpace (MEDP) at Hold
-
Medpace (MEDP) PT Lowered to $434 at TD Cowen
-
Medpace (MEDP) PT Lowered to $432 at Guggenheim
-
Medpace (MEDP) PT Lowered to $415 at Jefferies
-
Medpace Holdings (MEDP) Tops Q2 EPS by 22c, provides guidance
-
Medpace (MEDP) PT Raised to $469 at Baird
-
Medpace (MEDP) PT Raised to $456 at Baird
-
Cabot Wealth shares top 10 stocks picks for this week

